Induced pluripotent stem cells, also called artificially induced pluripotent stem cells, often referred to as iPS cells, are pluripotent stem cells formed by dedifferentiation of mammalian adult cells by transfer of transcription factors and other means. It was first developed by Japanese scholar Shinya Yamanaka The research team discovered in 2006. Shinya Yamanaka's team used mouse cells as experimental materials when publishing the iPS induction technology. In 2007, researchers proved that iPS induction technology can be applied to human cells.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Induced Pluripotent Stem Cells industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Human iPSCs
Mouse iPSCs
Human iPSCs had a market share of 89% in 2018, followed by Mouse iPSCs.
Market Segment by Product Application
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Finally, the report provides detailed profile and data information analysis of leading company.
Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
ReproCELL
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Induced Pluripotent Stem Cells consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Induced Pluripotent Stem Cells market by identifying its various subsegments.
3.Focuses on the key global Induced Pluripotent Stem Cells manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Induced Pluripotent Stem Cells with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Induced Pluripotent Stem Cells submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Induced Pluripotent Stem Cells Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Induced Pluripotent Stem Cells Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Induced Pluripotent Stem Cells Segment by Type
2.1.1 Human iPSCs
2.1.2 Mouse iPSCs
2.1.3 Human iPSCs had a market share of 89% in 2018, followed by Mouse iPSCs.
2.2 Market Analysis by Application
2.2.1 Academic Research
2.2.2 Drug Development and Discovery
2.2.3 Toxicity Screening
2.2.4 Regenerative Medicine
2.3 Global Induced Pluripotent Stem Cells Market Comparison by Regions (2017-2027)
2.3.1 Global Induced Pluripotent Stem Cells Market Size (2017-2027)
2.3.2 North America Induced Pluripotent Stem Cells Status and Prospect (2017-2027)
2.3.3 Europe Induced Pluripotent Stem Cells Status and Prospect (2017-2027)
2.3.4 China Induced Pluripotent Stem Cells Status and Prospect (2017-2027)
2.3.5 Japan Induced Pluripotent Stem Cells Status and Prospect (2017-2027)
2.3.6 Southeast Asia Induced Pluripotent Stem Cells Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Induced Pluripotent Stem Cells Industry Impact
2.5.1 Induced Pluripotent Stem Cells Business Impact Assessment - Covid-19
2.5.2 Market Trends and Induced Pluripotent Stem Cells Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Induced Pluripotent Stem Cells Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Induced Pluripotent Stem Cells Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Induced Pluripotent Stem Cells Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Induced Pluripotent Stem Cells Manufacturer Market Share
3.5 Top 10 Induced Pluripotent Stem Cells Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Induced Pluripotent Stem Cells Market
3.7 Key Manufacturers Induced Pluripotent Stem Cells Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Induced Pluripotent Stem Cells Industry Key Manufacturers
4.1 Fujifilm Holding Corporation (CDI)
4.1.1 Compan Detail
4.1.2 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells Product Introduction, Application and Specification
4.1.3 Fujifilm Holding Corporation (CDI) 136 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Fujifilm Holding Corporation (CDI) News
4.2 Ncardia
4.2.1 Compan Detail
4.2.2 Ncardia Induced Pluripotent Stem Cells Product Introduction, Application and Specification
4.2.3 Ncardia Induced Pluripotent Stem Cells Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Fujifilm Holding Corporation (CDI) News
4.3 Sumitomo Dainippon Pharma
4.3.1 Compan Detail
4.3.2 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells Product Introduction, Application and Specification
4.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Sumitomo Dainippon Pharma News
4.4 Astellas Pharma Inc
4.4.1 Compan Detail
4.4.2 Astellas Pharma Inc Induced Pluripotent Stem Cells Product Introduction, Application and Specification
4.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Astellas Pharma Inc News
4.5 Fate Therapeutics, Inc
4.5.1 Compan Detail
4.5.2 Astellas Pharma Inc Induced Pluripotent Stem Cells Product Introduction, Application and Specification
4.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Fate Therapeutics, Inc News
4.6 Pluricell Biotech
4.6.1 Compan Detail
4.6.2 Pluricell Biotech Induced Pluripotent Stem Cells Product Introduction, Application and Specification
4.6.3 Pluricell Biotech Induced Pluripotent Stem Cells Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Pluricell Biotech News
4.7 Cell Inspire Biotechnology
4.7.1 Compan Detail
4.7.2 Cell Inspire Biotechnology Induced Pluripotent Stem Cells Product Introduction, Application and Specification
4.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 ReproCELL
4.8.1 Compan Detail
4.8.2 ReproCELL Induced Pluripotent Stem Cells Product Introduction, Application and Specification
4.8.3 ReproCELL Induced Pluripotent Stem Cells Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 ReproCELL News
5 Global Induced Pluripotent Stem Cells Market Segment by Big Type
5.1 Global Induced Pluripotent Stem Cells Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Induced Pluripotent Stem Cells Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Induced Pluripotent Stem Cells Revenue and Market Share by Big Type (2017-2022)
5.2 Human iPSCs Sales Growth Rate and Price
5.2.1 Global Human iPSCs Sales Growth Rate (2017-2022)
5.2.2 Global Human iPSCs Price (2017-2022)
5.3 Mouse iPSCs Sales Growth Rate and Price
5.3.1 Global Mouse iPSCs Sales Growth Rate (2017-2022)
5.3.2 Global Mouse iPSCs Price (2017-2022)
5.4 Human iPSCs had a market share of 89% in 2018, followed by Mouse iPSCs. Sales Growth Rate and Price
5.4.1 Global Human iPSCs had a market share of 89% in 2018, followed by Mouse iPSCs. Sales Growth Rate (2017-2022)
5.4.2 Global Human iPSCs had a market share of 89% in 2018, followed by Mouse iPSCs. Price (2017-2022)
6 Global Induced Pluripotent Stem Cells Market Segment by Big Application
6.1 Global Induced Pluripotent Stem Cells Sales Market Share by Big Application (2017-2022)
6.2 Academic Research Sales Growth Rate (2017-2022)
6.3 Drug Development and Discovery Sales Growth Rate (2017-2022)
6.4 Toxicity Screening Sales Growth Rate (2017-2022)
6.5 Regenerative Medicine Sales Growth Rate (2017-2022)
7 Global Induced Pluripotent Stem Cells Forecast
7.1 Global Induced Pluripotent Stem Cells Revenue, Sales and Growth Rate (2022-2027)
7.2 Induced Pluripotent Stem Cells Market Forecast by Regions (2022-2027)
7.2.1 North America Induced Pluripotent Stem Cells Market Forecast (2022-2027)
7.2.2 Europe Induced Pluripotent Stem Cells Market Forecast (2022-2027)
7.2.3 China Induced Pluripotent Stem Cells Market Forecast (2022-2027)
7.2.4 Japan Induced Pluripotent Stem Cells Market Forecast (2022-2027)
7.2.5 Southeast Asia Induced Pluripotent Stem Cells Market Forecast (2022-2027)
7.2.6 Other Regions Induced Pluripotent Stem Cells Market Forecast (2022-2027)
7.3 Induced Pluripotent Stem Cells Market Forecast by Type (2022-2027)
7.3.1 Global Induced Pluripotent Stem Cells Sales Forecast by Type (2022-2027)
7.3.2 Global Induced Pluripotent Stem Cells Market Share Forecast by Type (2022-2027)
7.4 Induced Pluripotent Stem Cells Market Forecast by Application (2022-2027)
7.4.1 Global Induced Pluripotent Stem Cells Sales Forecast by Application (2022-2027)
7.4.2 Global Induced Pluripotent Stem Cells Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Induced Pluripotent Stem Cells Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Induced Pluripotent Stem Cells Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Induced Pluripotent Stem Cells
Figure Market Concentration Ratio and Market Maturity Analysis of Induced Pluripotent Stem Cells
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Induced Pluripotent Stem Cells Market Size by Big Type
Figure Global Market Share of Induced Pluripotent Stem Cells by Big Type in 2021
Figure Human iPSCs Picture (2017-2022)
Figure Mouse iPSCs Picture (2017-2022)
Global Induced Pluripotent Stem Cells Market Size by Big Application
Table Global Induced Pluripotent Stem Cells Market Size by Application
Figure Global Induced Pluripotent Stem Cells Market Share by Big Application in 2021
Figure Academic Research Picture
Figure Drug Development and Discovery Picture
Figure Toxicity Screening Picture
Figure Regenerative Medicine Picture
Table Global Induced Pluripotent Stem Cells Comparison by Regions (M USD) (2017-2027)
Figure Global Induced Pluripotent Stem Cells Market Size (Million US$) (2017-2027)
Figure North America Induced Pluripotent Stem Cells Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Induced Pluripotent Stem Cells Revenue (Million US$) Growth Rate (2017-2027)
Figure China Induced Pluripotent Stem Cells Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Induced Pluripotent Stem Cells Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Induced Pluripotent Stem Cells Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Induced Pluripotent Stem Cells Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Induced Pluripotent Stem Cells Sales by Manufacturer (2017-2022)
Figure Global Induced Pluripotent Stem Cells Sales Market Share by Manufacturer in 2021
Table Global Induced Pluripotent Stem Cells Revenue by Manufacturer (2017-2022)
Figure Global Induced Pluripotent Stem Cells Revenue Market Share by Manufacturer in 2021
Table Global Induced Pluripotent Stem Cells Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Induced Pluripotent Stem Cells Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Induced Pluripotent Stem Cells Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Induced Pluripotent Stem Cells Market
Table Key Manufacturers Induced Pluripotent Stem Cells Product Type
Table Mergers & Acquisitions Planning
Table Fujifilm Holding Corporation (CDI) Company Profile
Table Induced Pluripotent Stem Cells Product Introduction, Application and Specification of Fujifilm Holding Corporation (CDI)
Table Induced Pluripotent Stem Cells Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Ncardia Company Profile
Table Induced Pluripotent Stem Cells Product Introduction, Application and Specification of Ncardia
Table Induced Pluripotent Stem Cells Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Ncardia Recent Development
Table Sumitomo Dainippon Pharma Company Profile
Table Induced Pluripotent Stem Cells Product Introduction, Application and Specification of Sumitomo Dainippon Pharma
Table Induced Pluripotent Stem Cells Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sumitomo Dainippon Pharma Main Business
Table Sumitomo Dainippon Pharma Recent Development
Table Astellas Pharma Inc Company Profile
Table Induced Pluripotent Stem Cells Product Introduction, Application and Specification of Astellas Pharma Inc
Table Induced Pluripotent Stem Cells Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Astellas Pharma Inc Main Business
Table Astellas Pharma Inc Recent Development
Table Astellas Pharma Inc Main Business
Table Astellas Pharma Inc Recent Development
Table Fate Therapeutics, Inc Company Profile
Table Induced Pluripotent Stem Cells Product Introduction, Application and Specification of Fate Therapeutics, Inc
Table Induced Pluripotent Stem Cells Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Fate Therapeutics, Inc Main Business
Table Fate Therapeutics, Inc Recent Development
Table Pluricell Biotech Company Profile
Table Induced Pluripotent Stem Cells Product Introduction, Application and Specification of Pluricell Biotech
Table Induced Pluripotent Stem Cells Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pluricell Biotech Main Business
Table Pluricell Biotech Recent Development
Table Cell Inspire Biotechnology Company Profile
Table Induced Pluripotent Stem Cells Product Introduction, Application and Specification of Cell Inspire Biotechnology
Table Induced Pluripotent Stem Cells Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cell Inspire Biotechnology Main Business
Table Cell Inspire Biotechnology Recent Development
Table ReproCELL Company Profile
Table Induced Pluripotent Stem Cells Product Introduction, Application and Specification of ReproCELL
Table Induced Pluripotent Stem Cells Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table ReproCELL Main Business
Table ReproCELL Recent Development
Figure Global Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure Global Induced Pluripotent Stem Cells Revenue and Growth Rate (2017-2022)
Table Global Induced Pluripotent Stem Cells Sales by Regions (2017-2022)
Figure Global Induced Pluripotent Stem Cells Sales Market Share by Regions in 2021
Table Global Induced Pluripotent Stem Cells Revenue by Regions (2017-2022)
Figure Global Induced Pluripotent Stem Cells Revenue Market Share by Regions in 2021
Figure North America Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure Europe Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure China Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure Japan Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure Southeast Asia Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure Other Regions Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Table Global Induced Pluripotent Stem Cells Sales by Big Type (2017-2022)
Table Global Induced Pluripotent Stem Cells Sales Market Share by Big Type (2017-2022)
Figure Global Induced Pluripotent Stem Cells Sales Market Share by Big Type in 2019
Table Global Induced Pluripotent Stem Cells Revenue by Big Type (2017-2022)
Table Global Induced Pluripotent Stem Cells Revenue Market Share by Big Type (2017-2022)
Table Global Induced Pluripotent Stem Cells Revenue Market Share by Big Type in 2019
Figure Global Human iPSCs Sales Growth Rate (2017-2022)
Figure Global Human iPSCs Price (2017-2022)
Figure Global Mouse iPSCs Sales Growth Rate (2017-2022)
Figure Global Mouse iPSCs Price (2017-2022)
Figure Global Human iPSCs had a market share of 89% in 2018, followed by Mouse iPSCs. Sales Growth Rate (2017-2022)
Table Global Induced Pluripotent Stem Cells Sales by Big Application (2017-2022)
Table Global Induced Pluripotent Stem Cells Sales Market Share by Big Application (2017-2022)
Figure Global Induced Pluripotent Stem Cells Sales Market Share by Big Application in 2019
Figure Global Academic Research Sales Growth Rate (2017-2022)
Figure Global Drug Development and Discovery Sales Growth Rate (2017-2022)
Figure Global Toxicity Screening Sales Growth Rate (2017-2022)
Figure Global Regenerative Medicine Sales Growth Rate (2017-2022)
Figure Global Induced Pluripotent Stem Cells Sales and Growth Rate (2022-2027)
Figure Global Induced Pluripotent Stem Cells Revenue and Growth Rate (2022-2027)
Table Global Induced Pluripotent Stem Cells Sales Forecast by Regions (2022-2027)
Table Global Induced Pluripotent Stem Cells Market Share Forecast by Regions (2022-2027)
Figure North America Sales Induced Pluripotent Stem Cells Market Forecast (2022-2027)
Figure Europe Sales Induced Pluripotent Stem Cells Market Forecast (2022-2027)
Figure China Sales Induced Pluripotent Stem Cells Market Forecast (2022-2027)
Figure Japan Sales Induced Pluripotent Stem Cells Market Forecast (2022-2027)
Figure Southeast Asia Sales Induced Pluripotent Stem Cells Market Forecast (2022-2027)
Figure Other Regions Sales Induced Pluripotent Stem Cells Market Forecast (2022-2027)
Table Global Induced Pluripotent Stem Cells Sales Forecast by Type (2022-2027)
Table Global Induced Pluripotent Stem Cells Market Share Forecast by Type (2022-2027)
Table Global Induced Pluripotent Stem Cells Sales Forecast by Application (2022-2027)
Table Global Induced Pluripotent Stem Cells Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Induced Pluripotent Stem Cells
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Induced Pluripotent Stem Cells Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Induced Pluripotent Stem Cells Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Induced Pluripotent Stem Cells Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Induced Pluripotent Stem Cells Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Induced Pluripotent Stem Cells Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Induced Pluripotent Stem Cells Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Induced Pluripotent Stem Cells Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Induced Pluripotent Stem Cells Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)